Anxious depression: Clinical features and treatment

Current Psychiatry Reports

Volumn 11, Issue 6, 2009, Pages 429-436

  Rao, Sanjai ^a   Zisook, Sidney ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CITALOPRAM; MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; ANXIOUS DEPRESSION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG ACTIVITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HUMAN; HUMAN RELATION; MAJOR DEPRESSION; MIXED ANXIETY AND DEPRESSION; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL PHOBIA; SUICIDAL BEHAVIOR; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; HUMANS; PSYCHOTHERAPY;

EID: 72849117237     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-009-0065-2     Document Type: Review

References (46)

1. M. Fava A.J. Rush J.E. Alpert, et al. 2006 What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension Can J Psychiatry 51 823 835 17195602
2. B.W. Dunlop P.G. Davis 2008 Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review Prim Care Companion J Clin Psychiatry 10 222 228 10.4088/PCC.v10n0307 18615162
3. S.H. Kennedy 2008 Treating each and every depressed patient J Psychopharmacol 22 19 23 10.1177/0269881108093270 1:STN:280: DC%2BD1cjpvFCktA%3D%3D 18753279
4. J.M. Hettema 2008 What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet 148C 140 146 10.1002/ajmg.c.30171 18412101 (Pubitemid 351705131)
5. K.S. Kendler C.O. Gardner M. Gatz N.L. Pedersen 2007 The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample Psychol Med 37 453 462 10.1017/S0033291706009135 17121688 (Pubitemid 46306623)
6. T.K. Melartin H.J. Rytsala U.S. Leskela, et al. 2002 Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study J Clin Psychiatry 63 126 134 11874213
7. M. Zimmerman W. McDermut J.I. Mattia 2000 Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder Am J Psychiatry 157 1337 1340 10.1176/appi.ajp.157.8.1337 1:STN:280:DC%2BD3cvgvVemtg%3D%3D 10910803 (Pubitemid 30659823)
8. M. Fava M.A. Rankin E.C. Wright, et al. 2000 Anxiety disorders in major depression Compr Psychiatry 41 97 102 10.1016/S0010-440X(00)90140-8 1:STN:280:DC%2BD3c3gtl2gsg%3D%3D 10741886
9. D.S. Hasin R.D. Goodwin F.S. Stinson B.F. Grant 2005 Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions Arch Gen Psychiatry 62 1097 1106 10.1001/archpsyc.62.10.1097 16203955 (Pubitemid 41396935)
10. R.C. Kessler K.A. McGonagle S. Zhao, et al. 1994 Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 8 19 1:STN:280:DyaK2c7gslSrtA%3D%3D 8279933
11. R.T. Joffe R.M. Bagby A. Levitt 1993 Anxious and nonanxious depression Am J Psychiatry 150 1257 1258 1:STN:280:DyaK3szhvV2rtg%3D%3D 8328574
12. Brown GW, Harris TO, Eales MJ: Social factors and comorbidity of depressive and anxiety disorders. Br J Psychiatry Suppl 1996, June:50-57.
13. M. Fava L.A. Uebelacker J.E. Alpert, et al. 1997 Major depressive subtypes and treatment response Biol Psychiatry 42 568 576 10.1016/S0006- 3223(96)00440-4 1:STN:280:DyaK1c%2FitV2qsQ%3D%3D 9376453 (Pubitemid 27425475)
14. G.D. Tollefson S.L. Holman M.E. Sayler J.H. Potvin 1994 Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features J Clin Psychiatry 55 50 59 1:STN:280:DyaK2czlslygsQ%3D%3D 8077155
15. P.J. Clayton W.M. Grove W. Coryell, et al. 1991 Follow-up and family study of anxious depression Am J Psychiatry 148 1512 1517 1:STN:280: DyaK38%2Fis1Gkug%3D%3D 1928465
16. N.M. Simon 2009 Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse J Clin Psychiatry 70 Suppl2 10 14 10.4088/JCP.s.7002.02 19371501
17. T.E. Moffitt H. Harrington A. Caspi, et al. 2007 Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years Arch Gen Psychiatry 64 651 660 10.1001/archpsyc.64.6.651 17548747 (Pubitemid 46878666)
18. T. Slade D. Watson 2006 The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population Psychol Med 36 1593 1600 10.1017/S0033291706008452 16882356 (Pubitemid 44575805)
19. N.M. Simon A.K. Zalta M.W. Otto, et al. 2007 The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder J Psychiatr Res 41 255 264 10.1016/j.jpsychires.2006.08. 004 17052730 (Pubitemid 44856732)
20. M. Fava A.J. Rush J.E. Alpert, et al. 2008 Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR D report Am J Psychiatry 165 342 351 10.1176/appi.ajp.2007.06111868 18172020 (Pubitemid 351704490)
21. M. Fava J.E. Alpert C.N. Carmin, et al. 2004 Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR D Psychol Med 34 1299 1308 10.1017/S0033291704002612 15697056 (Pubitemid 39517160)
22. J.M. Russell L.M. Koran J. Rush, et al. 2001 Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression Depress Anxiety 13 18 27 10.1002/1520-6394(2001)13:1<18::AID-DA3>3.0.CO;2- M 1:STN:280:DC%2BD3MzotFGisQ%3D%3D 11233456 (Pubitemid 32537090)
23. G.M. Van der Weele J. Gussekloo M.W. De Waal, et al. 2009 Co-occurrence of depression and anxiety in elderly subjects aged 90 years and its relationship with functional status, quality of life and mortality Int J Geriatr Psychiatry 24 595 601 10.1002/gps.2162 19031476
24. J.C. Nelson K. Delucchi L.S. Schneider 2009 Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis Int J Geriatr Psychiatry 24 539 544 10.1002/gps.2233 19334041
25. Domschke K, Deckert J, Arolt V, Baune B: Anxious versus non-anxious depression: difference in treatment outcome. J Psychopharmacol 2008 Oct 6 (Epub ahead of print).
26. J.E. Helzer H.C. Kraemer R.F. Krueger 2006 The feasibility and need for dimensional psychiatric diagnoses Psychol Med 36 1671 1680 10.1017/ S003329170600821X 16907995 (Pubitemid 44824729)
27. D.A. Regier 2007 Dimensional approaches to psychiatric classification: refining the research agenda for DSM-V: an introduction Int J Methods Psychiatr Res 16 Suppl1 S1 S5 10.1002/mpr.209 17623390 (Pubitemid 46930446)
28. A. Farabaugh D. Mischoulon M. Fava, et al. 2005 The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients Int Clin Psychopharmacol 20 87 91 10.1097/00004850-200503000-00004 15729083 (Pubitemid 40354397)
29. R.A. Schoevers H.L. Van V. Koppelmans, et al. 2008 Managing the patient with co-morbid depression and an anxiety disorder Drugs 68 1621 1634 10.2165/00003495-200868120-00002 1:CAS:528:DC%2BD1cXhtlKhsLfK 18681487
30. M.J. Panzer 2005 Are SSRIs really more effective for anxious depression? Ann Clin Psychiatry 17 23 29 10.1080/10401230590905317 15941028 (Pubitemid 40471681)
31. S. Zisook 1985 A clinical overview of monoamine oxidase inhibitors Psychosomatics 26 240 246 1:STN:280:DyaL2M7ptFaitg%3D%3D 3887453
32. J.D. Amsterdam 2003 A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder J Clin Psychiatry 64 208 214 1:CAS:528:DC%2BD3sXitlWjsLg%3D 12633131
33. M. Zimmerman M. Posternak M. Friedman, et al. 2004 Which factors influence psychiatrists' selection of antidepressants? Am J Psychiatry 161 1285 1289 10.1176/appi.ajp.161.7.1285 15229063 (Pubitemid 38859180)
34. G.I. Papakostas S.M. Stahl A. Krishen, et al. 2008 Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies J Clin Psychiatry 69 1287 1292 10.4088/JCP.v69n0812 1:CAS:528:DC%2BD1cXhtFSgs73O 18605812
35. S. Zisook A.J. Rush B.R. Haight, et al. 2006 Use of bupropion in combination with serotonin reuptake inhibitors Biol Psychiatry 59 203 210 10.1016/j.biopsych.2005.06.027 1:CAS:528:DC%2BD28XhtlaqurY%3D 16165100 (Pubitemid 43208965)
36. A.J. Flint 2005 Generalised anxiety disorder in elderly patients: epidemiology, diagnosis and treatment options Drugs Aging 22 101 114 10.2165/00002512-200522020-00002 15733018 (Pubitemid 40445321)
37. J.C. Nelson 2008 Anxious depression and response to treatment Am J Psychiatry 165 297 299 10.1176/appi.ajp.2007.07121927 18316424 (Pubitemid 351704479)
38. C. Brown H.C. Schulberg M.J. Madonia, et al. 1996 Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders Am J Psychiatry 153 1293 1300 1:STN:280:DyaK28vivVegtg%3D%3D 8831437 (Pubitemid 26334202)
39. J. Unutzer W. Katon C.M. Callahan, et al. 2002 Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial JAMA 288 2836 2845 10.1001/jama.288.22.2836 12472325 (Pubitemid 35425069)
40. S. Woody P.D. McLean S. Taylor W.J. Koch 1999 Treatment of major depression in the context of panic disorder J Affect Disord 53 163 174 10.1016/S0165-0327(98)00117-7 1:STN:280:DyaK1M3oslWmtA%3D%3D 10360411 (Pubitemid 29232356)
41. P.D. McLean S. Woody S. Taylor W.J. Koch 1998 Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy J Consult Clin Psychol 66 240 247 10.1037/0022-006X.66.2.240 1:STN:280:DyaK1c3ksVWlsA%3D%3D 9583327 (Pubitemid 28208306)
42. G.A. Fava C. Ruini C. Rafanelli, et al. 2004 Six-year outcome of cognitive behavior therapy for prevention of recurrent depression Am J Psychiatry 161 1872 1876 10.1176/appi.ajp.161.10.1872 15465985 (Pubitemid 39314682)
43. S.D. Hollon R.B. Jarrett A.A. Nierenberg, et al. 2005 Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry 66 455 468 15816788
44. P.J. van't Veer-Tazelaar H.W. van Marwijk P. van Oppen, et al. 2009 Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial Arch Gen Psychiatry 66 297 304 10.1001/archgenpsychiatry.2008. 555
45. M.H. Trivedi A.J. Rush B.N. Gaynes, et al. 2007 Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care Neuropsychopharmacology 32 2479 2489 10.1038/sj.npp.1301390 1:CAS:528:DC%2BD2sXhtlWjsbjI 17406651 (Pubitemid 350126843)
46. A. Szegedi W.T. Jansen A.P. van Willigenburg, et al. 2009 Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients J Clin Psychiatry 70 344 353 10.4088/JCP.07m03780 19254516